Page last updated: 2024-08-21

triflusal and clopidogrel

triflusal has been researched along with clopidogrel in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (37.50)29.6817
2010's5 (62.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borja, J1
Weinberger, J1
Ezekowitz, MD; Jamieson, DG; Parekh, A1
Acciarresi, M; Caso, V; Paciaroni, M; Pezzella, FR; Santalucia, P1
Kang, W; Kwon, KI; Lee, BY; Park, S; Yeul Ma, J; Yoon, YR; Yun, HY1
Ahn, SH; Han, SW; Kim, YJ; Kim, YN; Lee, KY; Oh, SH; Seo, WK; Yu, S1
Colás, C; Cubero, JL; Millán, P; Simó Sánchez, B1
de Abajo, FJ; García-Rodríguez, LA; Gil, M; Montoya, H; Rodríguez-Martín, S; Rodríguez-Miguel, A1

Reviews

3 review(s) available for triflusal and clopidogrel

ArticleYear
Adverse effects and drug interactions of antithrombotic agents used in prevention of ischaemic stroke.
    Drugs, 2005, Volume: 65, Issue:4

    Topics: Anticoagulants; Aspirin; Clopidogrel; Dipyridamole; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Salicylates; Stroke; Ticlopidine; Warfarin

2005
Review of antiplatelet therapy in secondary prevention of cerebrovascular events: a need for direct comparisons between antiplatelet agents.
    Journal of cardiovascular pharmacology and therapeutics, 2005, Volume: 10, Issue:3

    Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Stroke; Ticlopidine

2005
Antiplatelet treatment in primary and secondary stroke prevention in women.
    European journal of internal medicine, 2012, Volume: 23, Issue:7

    Topics: Aspirin; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Female; Humans; Naphthalenes; Platelet Aggregation Inhibitors; Primary Prevention; Propionates; Salicylates; Secondary Prevention; Sex Factors; Stroke; Ticlopidine

2012

Trials

1 trial(s) available for triflusal and clopidogrel

ArticleYear
Protocol for the comparison of triflusal and clopidogrel in secondary prevention of stroke based on cytochrome P450 2C19 genotyping (MASETRO study): A multicenter, randomized, open-label, parallel-group trial.
    International journal of stroke : official journal of the International Stroke Society, 2016, Volume: 11, Issue:4

    Topics: Brain Ischemia; Cerebral Hemorrhage; Chemoprevention; Clopidogrel; Cytochrome P-450 CYP2C19; Follow-Up Studies; Genotype; Humans; Pharmacogenomic Variants; Platelet Aggregation Inhibitors; Recurrence; Salicylates; Secondary Prevention; Single-Blind Method; Stroke; Ticlopidine; Treatment Outcome

2016

Other Studies

4 other study(ies) available for triflusal and clopidogrel

ArticleYear
Oral antiplatelet therapy.
    JAMA, 2005, Feb-16, Volume: 293, Issue:7

    Topics: Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Coronary Artery Disease; Humans; Platelet Aggregation Inhibitors; Salicylates; Ticlopidine

2005
Semi-mechanistic modelling and simulation of inhibition of platelet aggregation by antiplatelet agents.
    Basic & clinical pharmacology & toxicology, 2014, Volume: 115, Issue:4

    Topics: Adult; Blood Platelets; Cilostazol; Clopidogrel; Half-Life; Humans; Models, Theoretical; Platelet Aggregation; Platelet Aggregation Inhibitors; Retrospective Studies; Salicylates; Tetrazoles; Ticlopidine; Young Adult

2014
Aspirin desensitization in patients with coronary artery disease: Cost savings.
    Medicina intensiva, 2017, Volume: 41, Issue:7

    Topics: Aspirin; Clopidogrel; Coronary Disease; Cost Savings; Desensitization, Immunologic; Drug Hypersensitivity; Drug Substitution; Humans; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Salicylates; Ticlopidine

2017
Clopidogrel and Low-Dose Aspirin, Alone or Together, Reduce Risk of Colorectal Cancer.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2019, Volume: 17, Issue:10

    Topics: Aged; Aged, 80 and over; Aspirin; Case-Control Studies; Clopidogrel; Colorectal Neoplasms; Dual Anti-Platelet Therapy; Female; Humans; Logistic Models; Male; Middle Aged; Platelet Aggregation Inhibitors; Protective Factors; Risk Reduction Behavior; Salicylates; Spain

2019